Silyl modification of biologically active compounds. 10. Lipid type organosilicon derivatives of 8-hydroxyquinoline and n-(2-hydroxyethyl)-1,2,3,4- tetrahydro(sila, iso)quinolines

Chemistry of Heterocyclic Compounds

Volumn 41, Issue 5, 2005, Pages 613-624

  Segal, I ^a   Zablotskaya, A ^a   Lukevics, E ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

Alkylation; Phase transfer catalysis; Psychotropic activity; Silylation; Tetrahydroisoquinoline; Tetrahydroquinoline

Indexed keywords

EID: 24644501667     PISSN: 00093122     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10593-005-0192-6     Document Type: Article

References (26)

1. E. Lukevics, A. Zablotskaya, I. Segal, S. Germane, and Yu. Popelis, Khim. Geterotsikl. Soedin., 941 (2003).
2. A. Zablotskaya, I. Segal, S. Germane, I. Shestakova, E. Lukevics, T. Kniess, and H. Spies, Appl. Organometal. Chem., 16, 550 (2002).
3. A. Zablotskaya, I. Segal, A. Kemme, S. Germane, Yu. Popelis, E. Lukevics, R. Berger, and Kh. Shpis, Khim. Geterotsikl. Soedin., 543 (2002).
4. A. Zablotskaya, I. Segal, S. Germane, I. Shestakova, I. Domracheva, A. Nesterova, A. Geronikaki, and E. Lukevics, Khim. Geterotsikl. Soedin., 968 (2002).
5. A. Zablotska, I. Segal, A. Kemme, E. Lukevics, R. Berger, and H. Spies, Ann. Rep., FZR-270, 156 (1999);
6. Chem. Abstr., 132, 245324 (2000).
7. A. Zablotska, I. Segal, E. Lukevics, H.-J. Pietzsch, T. Kniess, and H. Spies, Ann. Rep., FZR-270, 143 (1999);
8. Chem. Abstr., 132, 245321 (2000).
9. A. Zablotskaya, I. Segal, E. Lukevics, A. Drews, T. Kniess, and H. Spies, Ann. Rep., FZR-312, 62 (2001).
10. A. Zablotskaya, I. Segal, S. Germane, I. Shestakova, E. Lukevics, A. Drews, and H. Spies, Ann. Rep., FZR-312, 64 (2001).
11. A. Zablotskaya, I. Segal, S. Germane, E. Lukevics, and H. Spies, Ann. Rep., FZR-312, 66 (2001).
12. E. Lukevics and A. Zablotskaya, Metalloorg. Khim., 6, 263 (1993).
13. R. F. Heier, L. A. Dolak, J. N. Duncan, D. K. Hyslop, M. F. Lipton, I. J. Martin, M. A. Mauragis, M. F. Piercey, N. F. Nichols, P. J. K. D. Schreur, M. W. Smith, and M. W. Moon, J. Med. Chem., 40, 639 (1997).
14. M. J. Mokrosz, A. J. Bojarski, B. Duszynska, E. Tatarczynska, A. Klodzinska, A. Deren-Wesolek, S. Charakchieva-Minol, and E. Chojnacka-Wojcik, Bioorg. Med. Chem., 7, 287 (1999).
15. D. Matecka, D. Lewis, R. B. Rothman, C. M. Dersch, F. H. E. Wojnicki, J. R. Glowa, A. C. DeVries, Agu Pert, and K. C. Rice, J. Med. Chem., 40, 705 (1997).
16. X. C. Siu, S. M. Kher, Z.-L. Zhou, V. Ilyin, S. A. Espitia, M. Tran, J. E. Hawkinson, R. M. Woodward, E. Weber, and J. F. W. Keanna, J. Med. Chem., 40, 730 (1997).
17. M. D. Mashkovskii, Medicinal Agents [in Russian], Meditsina, Moscow (1993).
18. A. Zablotskaya, S. K. Germane, I. Segal, and E. Lukevics, Latv. J. Chem., 79 (1993).
19. E. Lukevics, A. Zablotskaya, S. K. Germane, and I. Segal, Latv. J. Chem., 472 (1994).
20. E. Lukevics, I. Segal, A. Zablotskaya, and S. Germane, Khim. Geterotsikl. Soedin., 793 (1996).
21. E. Lukevics, I. Segal, and A. Zablotskaya, Abstr. Int. Symp. Phase-transfer Catalysis: Mechanism and Application in Organic Synthesis, Dedicated to the Memory of L. A. Yanovskaya, Saint Petersburg (1997), p. 51.
22. A. Zablotskaya, I. Segal, and E. Lukevics, Khim. Geterotsikl. Soedin., 1110, (2004).
23. T. K. Chakraborty and G. V. Reddy, J. Chem. Soc., Chem. Commun., 251 (1989).
24. E. Lukevics, I. Segal, T. V. Lapina, E. I. Boreko, G. V. Vladyko, L. V. Korobchenko, and A. N. Evstropov, Izv. Akad. Nauk LatvSSR, Ser. Khim., 720 (1986).
25. E. Lukevics, I. Segal, A. Zablotskaya, and S. Germane, Molecules, 180 (1997).
26. V. V. Prozorovskii, M. P. Prozorovskaya, and V. M. Demchenko, Pharmacol. Toxicol., 497 (1978).